drugset / Trial / NCT02033512

TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS

NCT02033512

NaSingle-groupOpen-labelTreatment

Summary

There is a dilemma and a permanent debate about side effects on drugs administered orally. The first-pass metabolism is related with many side effects, since the metabolites of these compounds affect the course of human physiology. Conventional hormone therapy by oral route has been used for relieving menopausal symptoms. Transdermal estrogens have not been used extensively in Brazilian women with menopausal symptomatology, however; recently a previous long term study has indicated no increased risk breast cancer or vasomotor disorders in menopausal women, using transdermal HRT.

Timeline

Start
2003-01
Primary completion
2004-01
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.25 %
Subject Estriol Unknown 0.1 % Other
Subject Progesterone Other / unclassified 10 %

Indications

No indication recorded.